| Takeda Pharma AG - Immunate S/D 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| 52715 | | 04 | | Immunate S/D 250 I.E. | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B02BD06 | | Von Willebrand Factor and Coagulation Factor Viii in Combination | | 01.01.2005 | | |
|
| Composition |
| Praeparatio cryodesiccata: factor VIII coagulationis humanus 250 U.I., corresp. Specific activity (albumin-corrected) 70 ± 30 U.I. pro proteina 1 mg, corresp. von Willebrand factor activity (VWF:CBA) ca. 38 U.I./ml.
albuminum humanum, glycinum, lysini hydrochloridum 25 mg, natrii chloridum, natrii citras dihydricus, calcii chloridum dihydricum, pro vitro corresp. natrium ca. 9.8 mg.
Solvens: aqua ad iniectabile, pro vitro corresp. in solutione recenter reconstituta 50 U.I./ml. |
| Packungsbestandteile |
| Injection preparation | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Factor Humanus von Willebrandi | 190 UI | | Blutgerinnungsfaktor Viii Vom Menschen | 250 UI |
| | | | Inactive agents | Dose |
|---|
| Human Albumin | | | Calcium Chloride | | | Glycin | | | Lysine Hydrochloride | 25 mg | | Sodium Chloride | | | Natrii Citras Dihydricus | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 016 | 250 IE | 191.14 | 237.15 | B | SL | Yes |
|
